title: Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome?
authors.affiliation: Service d'Endocrinologie et Métabolisme, Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpétrière, 75013 Paris, France. eric.bruckert@psl.aphp.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Bruckert
authors.forename: Emilie
authors.initials: E
authors.lastname: Duchêne
authors.forename: Dominique
authors.initials: D
authors.lastname: Bonnefont-Rousselot
authors.forename: Boris
authors.initials: B
authors.lastname: Hansel
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Ansquer
authors.forename: André
authors.initials: A
authors.lastname: Dubois
authors.forename: Bertrand
authors.initials: B
authors.lastname: Gaymard
mesh_terms: D001288:Attention; D004311:Double-Blind Method; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012890:Sleep; D012891:Sleep Apnea Syndromes / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids; D010919:Placebos; D011345:Fenofibrate